Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Mylan deal with Roche clears path to biosimilar Herceptin launch

Mylan deal with Roche clears path to biosimilar Herceptin launch being the first company to launch a biosimilar to Herceptin in the US". ... two companies have already launched their copycat Herceptin in 14 emerging markets, including India.

2016: The year when deal-makers took stock?

2016: The year when deal-makers took stock? Canada for biosimilar versions of Rituxan (rituximab) and Herceptin (trastuzumab). .

Genentech names Anderson new CEO as Ian Clark retires

Genentech names Anderson new CEO as Ian Clark retires Big-selling brands such as breast cancer therapy Herceptin (trastuzumab), Avastin (bevacizumab) for solid tumours and MabThera/Rituxan (rituximab) for non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are

NICE backs Roche’s Perjeta for routine NHS use

NICE backs Roche’s Perjeta for routine NHS use Given in combination with Herceptin (trastuzumab) and docetaxel, Perjeta (pertuzumab) was recommended to treat women with HER2-positive, locally advanced, inflammatory or early-stage breast cancer at high risk of recurrence. ... preparation for surgery

Boehringer says Avastin biosimilar on track as Phase III gets underway

Boehringer says Avastin biosimilar on track as Phase III gets underway Avastin has been on the market since 2004 and along with breast cancer drug Herceptin (trastuzumab) has been the mainstay of Roche's cancer portfolio, bringing in nearly $7bn in sales

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics